Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04229342
Other study ID # POEM001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 6, 2020
Est. completion date October 6, 2020

Study information

Verified date October 2020
Source Asian Institute of Gastroenterology, India
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, we will evaluate the incidence of reflux esophagitis between two different techniques of posterior per-oral endoscopic myotomy (POEM) i.e. conventional POEM versus oblique/ sling fiber sparing POEM. This is a randomized trial where the patients with idiopathic achalasia will be randomized in two groups in 1:1 fashion into groups.


Description:

In this randomized trial, patients with idiopathic achalasia will undergo POEM using two techniques as follows. In the first technique, a conventional posterior POEM will be performed where the sling or oblique fibers will not be spared during POEM. Sling or oblique fibers will be recognized using the configuration of fibers below the gastroesophaeal junction and by identifying the border between the sling fibers and the circular fibers which is formed by the penetrating vessels. In the second group (Oblique fiber group), the sling fibers will be selectively spared and only the circular fibers will be spared. The other steps of the POEM procedure will be the same as described in the standard technique of POEM. These include submucosal injection of saline mixed with indigo carmine dye, mucosal incision, submucosal tunneling using triangular knife in spray coagulation mode (Effect 2, Watts 50), myotomy extending upto 2-4 cm below the gastroesophageal junction and the closure of mucosal incision using endoclips. Post POEM management: All the patients will be kept nil per oral for about 24-hours after the procedure. A timed barium swallow will be performed the next day and oral liquids will be started. A soft puried diet will be started from day 3 onwards. Oral proton pump inhibitors (PPIs) equivalent to 40 mg of Pantoprazole per day will be prescribed to all the patients unless a contraindication exists. Follow-up: The first evaluation will be performed at 2-months after POEM. During this evaluation, the following parameters will be recorded: symptom relief, reflux symptoms, and esophageal acid exposure. PPIs will be stopped for 1-2 weeks prior to the evaluation of GERD. Subsequent evaluation will be at 6-months for reflux symptoms and symptoms of achalasia using Eckardt scores.


Recruitment information / eligibility

Status Completed
Enrollment 114
Est. completion date October 6, 2020
Est. primary completion date July 16, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. Patients with type 1 and 2 achalasia with Eckardt score >3 (0-12 scale achalasia). 2. Patients with age 18-75 years. 3. Patients who are treatment naïve or have a history of pneumatic balloon dilatation. 4. Patients who are willing and able to comply with the study procedures and provide written informed consent form to participate in the study Exclusion Criteria: 1. Patients with type 3 achalasia cardia or any other esophageal motility disorder, 2. Patients who have undergone previous surgery of the esophagus or stomach, 3. Patients with active severe esophagitis, 4. Patients with large lower esophageal diverticula, 5. Patients with large ( > 3cm ) hiatal hernia, 6. Patients with sigmoid oesophagus,

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Per-oral endoscopic myotomy
Per-oral endoscopic myotomy (POEM) is an endoscopic modality for the management of achalasia cardia. In this study, we will evaluate the impact of two different techniques of posterior POEM on the incidence of gastroesophageal reflux disease (GERD). Posterior POEM will be performed using the standard technique. The myotomy beyond the GEJ will be different in the two groups. In one group, the sling fibers will not be spared from dissection and in the second group, the sling fibers will be selectively spared from myotomy.

Locations

Country Name City State
India Asian institute of Gastroenterology/AIG Hospitals Hyderabad Telangana

Sponsors (1)

Lead Sponsor Collaborator
Asian Institute of Gastroenterology, India

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Significant Reflux Esophagitis, Los Angeles grade (=grade B) Assessment of reflux esophagitis will be done at 8 weeks post procedure using Los Angeles grading system (grade A to D) 8 weeks
Secondary Clinical Success, Eckardt Score (minimum: 0, maximum: 12), Eckardt Score=3: success, >3: failure Clinical success will be evaluated using Eckardt scores 8 weeks
Secondary Clinical success using Eckardt Score (minimum:0, maximum: 12) Clinical success will be evaluated using Eckardt scores. Eckardt Score=3 will be considered as clinical success and >3 will be considered as clinical failure 6 months
Secondary Esophageal manometry Esophageal manometry will be performed at 8 weeks and Integrated relaxation pressure will be calculated and presented in mmHg 5. Change in IRP pressure by Manometry ( Assessed at pre procedure & 8 weeks). 8 weeks
Secondary Barium column height on Timed barium swallow; Success: >50% reduction in barium column height Timed barium swallow will be performed after POEM procedure and Esophageal emptying will be seen and compared with pre-POEM timed barium esophagogram 2 months
Secondary Esophageal acid exposure, Acid exposure time>6 abnormal, <4: normal, 4-6: inconclusive 24-hour pH impedance study will be performed at 8-weeks and esophageal acid exposure will be calculated 8 weeks
Secondary Reflux Symptoms, GERD HRQL score (minimum score: 0, maximum score: 50) The symptoms of gastroesophageal reflux will be evaluated using symptom scores. 8-weeks
Secondary Gastroesophageal reflux with DeMeester score at 8-weeks: DeMeester score=14.7 abnormal, <14.7: normal DeMeester scores will be calculated at 8 weeks after the POEM procedure 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06084572 - Prospective Evaluation of pH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
Completed NCT03568825 - Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose N/A
Recruiting NCT04703374 - A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects Phase 1
Completed NCT04120025 - Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients N/A
Withdrawn NCT04771247 - Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy N/A
Completed NCT02575287 - Minimal Injuries From Esophagus Detected by Optical Enhancement System™ Associated to Optical Magnification HD Scopes N/A
Completed NCT01710800 - Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy N/A
Completed NCT00287339 - The Utility of Nexium in Chronic Cough and Reflux Disease Phase 4
Completed NCT00287391 - Sleep Disorders and Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT00629564 - An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT04243668 - ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA) N/A
Completed NCT03558477 - PK/PD Clinical Trial of YYD601 in Healthy Adult Male Phase 1
Recruiting NCT05042063 - Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
Completed NCT05069493 - Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing
Terminated NCT04626232 - Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients N/A
Completed NCT03238534 - Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS Phase 4
Recruiting NCT05974722 - Mesh Vs Pledgets for Repair of Paraesophageal Hernia N/A
Recruiting NCT05781347 - Stretta Versus Conservative Treatment in Obese and Non-obese N/A
Completed NCT06141577 - A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects Phase 1
Recruiting NCT05108038 - A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects Phase 1